{"DataElement":{"publicId":"2694766","version":"1","preferredName":"Treatment Subsequent Biological Response Modifier ROADS Third Course Type Code","preferredDefinition":"Codes for the type of biological response modifier therapy given as part of the third course of treatment.","longName":"2694764v1.0:2654987v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2694764","version":"1","preferredName":"Treatment Subsequent Biological Response Modifier Third Course","preferredDefinition":"Biological response modifier therapy given as part of the second course of treatment.","longName":"2693447v1.0:2694762v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2693447","version":"1","preferredName":"Therapeutic Procedure Next","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Subsequent; immediately following in time or order.","longName":"C49236:C53286","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Next","conceptCode":"C53286","definition":"Subsequent; immediately following in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E6B6C46-0930-3265-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-08","modifiedBy":"ONEDATA","dateModified":"2007-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2694762","version":"1","preferredName":"Biological Response Modifier Third Course","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.:Following the second position in an ordering or series.:A period of protocol-prescribed activity or intervention.","longName":"C308:C25260:C25379","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Third","conceptCode":"C25260","definition":"Following the second position in an ordering or series; coming next after the second and just before the fourth in position.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E80132D-866C-3041-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-09","modifiedBy":"ONEDATA","dateModified":"2007-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E80132D-867D-3041-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2654987","version":"1","preferredName":"Biological Response Modifier ROADS Type Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host._ROADS_Type; a subdivision of a particular kind of thing._A system of numbered categories for representation of data.","longName":"2654987v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2645264","version":"1","preferredName":"Biological Response Modifier Type Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.:Type; a subdivision of a particular kind of thing.:A system of numbered categories for representation of data.","longName":"C308:C25284:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567AC-6ACC-2A08-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"ONEDATA","dateModified":"2007-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32E07C4D-3A4B-54CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-14","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-14","modifiedBy":"CURTIST","dateModified":"2010-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3103505","version":"1","longName":"NAACCR 11.1","context":"PS-CC"},{"publicId":"5899850","version":"1","longName":"TreatmentSubsequent16","context":"PS-CC"},{"publicId":"3103506","version":"1","longName":"NAACCR 11.2","context":"PS-CC"},{"publicId":"3103507","version":"1","longName":"NAACCR 11.3","context":"PS-CC"},{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464324","version":"1","longName":"TreatmentSubsequent18","context":"PS-CC"}]}],"AlternateNames":[{"name":"1695","type":"NAACCR Item #","context":"PS-CC"},{"name":"SUBSQ RX 3RD COURSE BRM","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Subsq RX 3rd Course BRM","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Subsequent RX 3rd Course BRM","type":"Preferred Question Text","description":"Subsequent RX 3rd Course BRM","url":null,"context":"PS-CC"},{"name":"NAACCR, V 11.1 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)","url":"http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf","context":"PS-CC"},{"name":"Subsq RX 3rd Course BRM Description","type":"COMMENT","description":"Central registries currently collecting this data item should follow the 1998 ROADS Manual coding instructions. The codes are the same as those for Immunotherapy, 1998 ROADS Manual, p. 243","url":null,"context":"PS-CC"},{"name":"NAACCR V11.2 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d","context":"PS-CC"},{"name":"NAACCR V11.3 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d","context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E802277-D51F-35BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-09","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}